Home › Merkel Cell Carcinoma › Texas › Houston
Merkel Cell Carcinoma clinical trials in Houston, TX
6 studies for Merkel Cell Carcinoma are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RecruitingPhase 1/2
- MD Anderson Cancer Center, Houston
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
RecruitingPhase 2
- M D Anderson Cancer Center, Houston
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Research Site, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- The University of Texas, MD Anderson Cancer Center, Houston
Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
RecruitingPhase 2
- M D Anderson Cancer Center, Houston
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
RecruitingPhase 2/3
- The University of Texas MD Anderson Cancer Center, Houston
Merkel Cell Carcinoma trials in other cities
- Boston, MA5 studies
- Tampa, FL4 studies
- New York City, NY4 studies
- San Antonio, TX4 studies
- Seattle, WA3 studies
- Queens, NY3 studies
- Los Angeles, CA3 studies
- Arlington, VA3 studies
- Pittsburgh, PA3 studies
- Miami, FL3 studies
- Jacksonville, FL3 studies
- St. Louis, MO3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.